Medline Inc. (MDLN) income statement
NASDAQ · Healthcare · Medical - Instruments & Supplies · 45,000 employees · CEO James Boyle
- Price
- $37.55 0.0%
- Market cap
- $32.5B
- Enterprise value
- $42.8B Data as of 2026-11-22
- Last report
- Q3 '26 filed 2026-11-04
- Next report
- 2027-02-24 EPS est. $0.39
Medline Inc. (MDLN) reported revenue of $7.86B for Q3 '26 (+10.4% year on year), operating income of $500M (6.4% of revenue) and net income of $195M. Over the last four quarters revenue was $30.7B.
Income statement
| Income statement | Trend | Q2 '24 | Q3 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | Q2 '26 | Q3 '26 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $6.19B | $6.39B | $6.64B | $6.89B | $7.12B | $7.79B | $7.35B | $7.69B | $7.86B | |
| Cost of revenue | $4.69B | $4.8B | $5B | $5.16B | $5.42B | $5.87B | $5.69B | $5.47B | $5.93B | |
| Gross profit | $1.49B | $1.58B | $1.65B | $1.73B | $1.7B | $1.91B | $1.67B | $2.22B | $1.93B | |
| General & administrative | $0 | $0 | $0 | $1.09B | $0 | $0 | $0 | $0 | $1.26B | |
| Other operating expenses | $2M | $22M | -$42M | $1M | $8M | $224M | $15M | $525M | $166M | |
| Operating expenses | $978M | $1.01B | $1.06B | $1.09B | $1.12B | $1.49B | $1.24B | $1.82B | $1.43B | |
| Operating income | $516M | $574M | $591M | $642M | $574M | $425M | $422M | $395M | $500M | |
| Interest income | $75M | $73M | $34M | $30M | $35M | $0 | $29M | $49M | $47M | |
| Interest expense | $267M | $174M | $214M | $233M | $228M | $166M | $165M | $168M | $165M | |
| Other non-operating income (gains on investments, FX ...) | -$51M | $62M | $39M | $80M | $1M | $219M | -$5M | -$8M | -$51M | |
| Total non-operating income | -$216M | -$236M | -$253M | -$283M | -$229M | -$219M | -$131M | -$160M | -$114M | |
| Income before tax | $300M | $338M | $338M | $359M | $345M | $206M | $291M | $235M | $386M | |
| Income tax | $8M | $14M | $16M | $26M | $23M | $26M | $52M | $96M | $68M | |
| Net income | $292M | $324M | $322M | $333M | $322M | $180M | $129M | $60M | $195M | |
| EPS (basic) | $0.37 | $0.41 | $0.40 | $0.42 | $0.41 | $0.22 | $0.16 | $0.07 | $0.22 | |
| EPS (diluted) | $0.37 | $0.41 | $0.40 | $0.42 | $0.41 | $0.22 | $0.16 | $0.07 | $0.22 | |
| Shares (basic, weighted) | 787M | 787M | 800M | 787M | 787M | 812M | 819M | 857M | 876M | |
| Shares (diluted, weighted) | 787M | 787M | 800M | 787M | 787M | 812M | 825M | 861M | 1.32B | |
| Depreciation & amortization | $239M | $248M | $247M | $250M | $253M | $261M | $254M | $256M | $259M | |
| EBITDA | $806M | $760M | $799M | $812M | $826M | $467M | $681M | $659M | $810M |
| Income statement | Trend | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Revenue | $21.4B | $23.2B | $25.5B | $28.4B | |
| Cost of revenue | $16.9B | $18B | $19.2B | $20.9B | |
| Gross profit | $4.56B | $5.22B | $6.29B | $7.52B | |
| Research & development | $58M | $60M | $67M | $0 | |
| General & administrative | $0 | $3.81B | $4.04B | $0 | |
| Other operating expenses | $11M | $106M | $37M | $782M | |
| Operating expenses | $3.69B | $3.97B | $4.15B | $5.31B | |
| Operating income | $870M | $1.25B | $2.15B | $2.21B | |
| Interest income | $27M | $237M | $280M | $0 | |
| Interest expense | $911M | $1.38B | $1.31B | $812M | |
| Other non-operating income (gains on investments, FX ...) | -$51M | -$152M | -$129M | $964M | |
| Total non-operating income | -$860M | -$986M | -$900M | -$964M | |
| Income before tax | $10M | $264M | $1.25B | $1.25B | |
| Income tax | $35M | $30M | $46M | $91M | |
| Net income | -$25M | $234M | $1.2B | $1.16B | |
| EPS (basic) | -$0.03 | $0.30 | $1.52 | $1.43 | |
| EPS (diluted) | -$0.03 | $0.30 | $1.52 | $1.43 | |
| Shares (basic, weighted) | 787M | 787M | 787M | 812M | |
| Shares (diluted, weighted) | 787M | 787M | 787M | 812M | |
| Depreciation & amortization | $933M | $951M | $977M | $1.01B | |
| EBITDA | $1.85B | $2.35B | $3.25B | $2.26B |
Standardised from the company's filings; outflows and costs keep the sign the provider reports. Hover a period for its end date. Amounts in USD.
Revenue, operating income and growth
quarterlyMargins
quarterlyCosts as % of revenue
quarterlyThe other statements
Sources
Statements, segment revenue, metrics and estimates are standardised from the company's filings. Segment profits and every reported line: SEC EDGAR (XBRL). Filings read: 10-Q 2026-09-26, 10-Q 2026-06-27, 10-Q 2026-03-28, 10-K 2025-12-31
Data as of 2026-11-22